RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 518 - per page Next page
Order by
Lotuzol, a new paradyme of anti-depressant
Lotuzol is a new herbal drug composing water extract powder of Nelumbinis Semen to treat depression without sexual dysfunction, a major adverse effect in commonly used anti-depressants. More
On-Demand Protein Microarrays: In Vitro Assembly of Protein Microarrays
A DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation. More
Prolactin Receptor Antibodies as a Diagnostic Marker and Therapeutic Agent for Cancer
This technology describes several antibodies, both polyclonal and monoclonal, to the prolactin receptor. More
METHODS FOR SCREENING A THERAPEUTIC AGENT OF HEART FAILURE, FIBROSIS AND INFLAMMATION AND COMPOSITIONS COMPRISING THE SAME
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Highly infectious nucleic acid molecules from pepper mottle virus and plant viral vector derived from the same
Pepper is a is the most widely cultivated species occupying about 31% (ca. 120,000 ha) of total vegetable-cultivating area (386,000 ha in 2000 year) and are produced on about 1,735,650 ha in 2005 in worldwide, about 60% (1,040,140 ha) of which are grown i More
Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors
Identification of mutations in fibroblast growth factor receptor 4 (FGFR4) that are associated with Rhabdomyosarcoma tumors; may be used to identify candidates for treatment with an FGFR4 inhibitor as an adjuvant to standard anticancer therapy. More
Gene Signature for Predicting Hepatocellular Carcinoma Patient Prognosis
A method of predicting the prognosis of a patient diagnosed with HCC by detecting expression of one of more HCC-associated genes, and a method of identifying an agent for use in treating HCC More
Risk–adapted therapy for multiple myeloma patents harboring the TP53 Deletion: The adverse consequences in Total Therapy 2 are overcome by addition of Bortezomib in Total Therapy 3 to treat the disease (09-30)
Gene array analysis and genetic testing uncovering a TP53 genetic deletion in multiple myeloma patients in combination with the use of risk-adapted therapy that incorporates thalidomide with bortezomib vastly improves patent outcomes. More
Direct Selection of Hybridomas (DiSH) for the Production of Monoclonal Antibodies
Direct Selection of Hybridomas (DiSH) for the Production of Monoclonal Antibodies More
A Novel in vivo Quantitative Molecular Screening System for Identification and Evaluation of Anti-Inflammatory Phytocompounds/Drugs
A Novel in vivo Quantitative Molecular Screening System for Identification and Evaluation of Anti-Inflammatory Phytocompounds/Drugs More
Displaying 1..10 of 518 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Med Discovery SA – Product Pipeline Review – Q1 2011
Apr 2011 - 24 pages - $500
Jenrin Discovery, Inc. – Product Pipeline Review – Q1 2011
May 2011 - 32 pages - $500
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
Jun 2010 - 411 pages - $2,695
Med Discovery SA – Product Pipeline Review – Q4 2010
Dec 2010 - 27 pages - $500
Dementia - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Dermatophytosis - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Herpes - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Esophagitis - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Filariasis - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us